ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Imfinzi 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung - 
66548002 AstraZeneca AG
Imfinzi 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung11.06.2018
  11.06.2018
(L01FF03) 
WHO-DDD 
07.16.10. 
07.16.10. 
A  
Yes 
IP 
2123.36Yes
    
10 %2325.70
  
7680665480022Biotechnologika
7452366 
Composition
durvalumabum 500 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 10 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Durvalumabum500mg / 10ml
BAG: Active AgentDose
Durvalumabum500 mg
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 80
Trehalosum Dihydricum
 
Source
Data was imported : 07.12.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home